Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
GeneDx Holdings Corp. - Class A Common Stock
(NQ:
WGS
)
165.61
-1.90 (-1.13%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
489,377
Open
167.51
Bid (Size)
162.68 (100)
Ask (Size)
183.24 (100)
Prev. Close
167.51
Today's Range
162.25 - 170.75
52wk Range
55.17 - 167.72
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Option Care Health Bring Home Hefty Share Price Gains; Earns RS Rating Upgrade
↗
Today 3:00 EST
The upgraded 74 RS Rating shows that the Chicago area-based home health care firm tops more than 70% of stocks for price performance.
Via
Investor's Business Daily
GeneDx Holdings Corp (NASDAQ:WGS) Presents a Strong Case for Growth Momentum and Technical Breakout
↗
November 20, 2025
GeneDx (WGS) shows explosive earnings growth of 1,125% and strong technicals, presenting a high-growth momentum and breakout opportunity.
Via
Chartmill
Performance
YTD
+108.0%
+108.0%
1 Month
+26.7%
+26.7%
3 Month
+31.2%
+31.2%
6 Month
+136.6%
+136.6%
1 Year
+105.8%
+105.8%
More News
Read More
Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake?
↗
November 19, 2025
Via
The Motley Fool
6 Healthcare Stocks With Strong Upward Momentum
↗
November 18, 2025
Via
Benzinga
Earnings Scheduled For October 28, 2025
↗
October 28, 2025
Via
Benzinga
GeneDx Hldgs's Earnings: A Preview
↗
October 27, 2025
Via
Benzinga
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit?
↗
November 14, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit?
↗
November 12, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing
↗
November 11, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Regulatory Compliance
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
November 06, 2025
From
GeneDx
Via
Business Wire
GeneDx Holdings Corp (NASDAQ:WGS) Emerges as a Premier Growth and Momentum Stock
↗
November 05, 2025
Via
Chartmill
GeneDx to Participate in Upcoming Investor Conferences
November 04, 2025
From
GeneDx
Via
Business Wire
What Does the Market Think About GeneDx Holdings Corp?
↗
October 31, 2025
Via
Benzinga
GeneDx (WGS) Q3 2025 Earnings Call Transcript
↗
October 28, 2025
Via
The Motley Fool
Topics
Earnings
GeneDx Holdings Corp (NASDAQ:WGS) Q3 2025 Earnings Beat Estimates and Drive Stock Higher
↗
October 28, 2025
Via
Chartmill
Topics
Earnings
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
October 28, 2025
From
GeneDx
Via
Business Wire
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
October 24, 2025
From
Halper Sadeh LLC
Via
Business Wire
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
October 22, 2025
From
GeneDx
Via
Business Wire
4 Analysts Assess GeneDx Holdings: What You Need To Know
↗
October 20, 2025
Via
Benzinga
GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing
October 20, 2025
From
GeneDx
Via
Business Wire
This WillScot Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
October 20, 2025
Via
Benzinga
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
October 14, 2025
From
GeneDx
Via
Business Wire
GeneDx Holdings Corp (NASDAQ:WGS) Presents a High-Growth Momentum and Technical Breakout Case
↗
October 14, 2025
Via
Chartmill
GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program
October 13, 2025
From
GeneDx
Via
Business Wire
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
October 09, 2025
From
GeneDx
Via
Business Wire
Frequently Asked Questions
Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 165.61
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 11/26/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.